Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Jin Yang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	62,163	64,938	66,504	66,805	70,257	78,689
Market Cap Growth	-12.75%	-2.35%	-0.45%	-4.91%	-10.72%	0.57%
Enterprise Value	133,031	137,575	148,150	73,349	78,626	79,706
Last Close Price	4815.00	5030.00	5652.12	5859.13	6021.93	6356.42
PE Ratio	2.79	2.91	2.24	5.28	5.71	8.25
PS Ratio	0.52	0.54	0.59	0.71	0.92	1.25
PB Ratio	0.39	0.41	0.56	0.75	0.91	1.21
P/TBV Ratio	0.41	0.42	0.58	0.79	0.95	1.24
P/FCF Ratio	-	-	-	8.51	16.61	-
P/OCF Ratio	42.43	44.33	5.20	7.83	9.43	39.93
EV/Sales Ratio	1.10	1.14	1.31	0.78	1.03	1.27
EV/EBITDA Ratio	26.96	27.88	10.79	6.25	5.86	8.74
EV/EBIT Ratio	52.66	54.46	12.65	8.07	7.06	11.45
EV/FCF Ratio	-47.50	-	-	9.34	18.59	-
Debt / Equity Ratio	0.48	0.48	0.67	0.14	0.26	0.31
Debt / EBITDA Ratio	15.55	15.55	5.80	1.10	1.49	2.20
Debt / FCF Ratio	-	-	-	1.65	4.72	-
Net Debt / Equity Ratio	0.44	0.44	0.65	0.05	0.12	0.08
Net Debt / EBITDA Ratio	14.36	14.36	5.66	0.37	0.71	0.56
Net Debt / FCF Ratio	-25.30	-25.30	-1.00	0.55	2.24	-9.41
Asset Turnover	0.49	0.49	0.65	0.80	0.72	0.74
Inventory Turnover	2.81	2.81	2.72	2.24	2.50	3.41
Quick Ratio	0.33	0.33	1.44	1.24	0.98	1.16
Current Ratio	0.52	0.52	2.19	1.96	1.50	1.51
Return on Equity (ROE)	15.93%	15.93%	28.35%	15.15%	17.23%	16.79%
Return on Assets (ROA)	0.64%	0.64%	4.21%	4.85%	6.54%	5.12%
Return on Invested Capital (ROIC)	0.93%	0.94%	6.44%	10.04%	11.98%	9.16%
Return on Capital Employed (ROCE)	1.40%	1.40%	5.60%	9.50%	13.30%	9.80%
Earnings Yield	35.85%	34.32%	44.65%	18.95%	17.52%	12.12%
FCF Yield	-4.51%	-4.31%	-116.19%	11.75%	6.02%	-0.69%
Payout Ratio	7.69%	7.69%	5.45%	12.77%	9.08%	11.72%
Buyback Yield / Dilution	-	-	1.17%	7.18%	-17.77%	-2.12%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.